Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Thermo Fisher was the world's biggest manufacturer in the Procalcitonin (CAS 56645-65-9) industry, accounted for 13% market share of the global market, followed by Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis.The top 5 companies had a combined market share of 35% of the global total.Europe was the largest consumption and production area in the world in 2018.

The global Procalcitonin (CAS 56645-65-9) market is valued at 66 million US$ in 2020 is expected to reach 108.5 million US$ by the end of 2026, growing at a CAGR of 7.3% during 2021-2026.
This report focuses on Procalcitonin (CAS 56645-65-9) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Procalcitonin (CAS 56645-65-9) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and South Korea etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Procalcitonin (CAS 56645-65-9) market is segmented into
Procalcitonin Antigen
Procalcitonin Antibody
The segment of antigen holds a comparatively larger share in global market, which accounts for about 70%.

Segment by Application
Medical Industry
Scientific Research
Veterinarian
The medical industry holds an important share in terms of applications, and accounts for 90% of the market share.

Global Procalcitonin (CAS 56645-65-9) Market: Regional Analysis
The Procalcitonin (CAS 56645-65-9) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Procalcitonin (CAS 56645-65-9) market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Procalcitonin (CAS 56645-65-9) Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Procalcitonin (CAS 56645-65-9) market include:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis